Pedestrians walk past Purdue Pharma’s headquarters in Stamford, Conn. The company filed for bankruptcy last month as part of a tentative deal to settle claims that it fueled the U.S. opioid epidemic by recklessly pushing sales of its addictive OxyContin painkiller.

Pedestrians walk past Purdue Pharma’s headquarters in Stamford, Conn. The company filed for bankruptcy last month as part of a tentative deal to settle claims that it fueled the U.S. opioid epidemic by recklessly pushing sales of its addictive OxyContin painkiller.